Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Lymphoma, non-Hodgkin lymphoma, adult
At Hospital/Institution:  Presbyterian - St. Luke's Medical Center
Trial Status:  Active
Results 1-9 of 9 for your search:
Start Over
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2448.00, NCI-2010-02035, P01CA018029, P30CA015704, NCT01231412
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: NCI
Protocol IDs: NCI-2014-00118, ECOG-E1912, E1912, U10CA180820, U10CA021115, NCT02048813
Sirolimus, Cyclosporine, and Mycophenolate Mofetil In Preventing Graft-Versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2206.00, NCI-2010-02222, P30CA015704, P01CA018029, NCT01251575
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: E1411, ECOG-E1411, NCI-2011-02980, CDR0000707057, NCT01415752
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 0 to 75
Sponsor: NCI, Other
Protocol IDs: 2546.00, NCI-2011-03828, P30CA015704, P01CA018029, NCT01527045
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00959, ECOG-E1412, E1412, U10CA180820, U10CA021115, NCT01856192
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Phase: No phase specified
Type: Natural history/Epidemiology, Tissue collection/Repository
Status: Active
Age: 0 to 21 years
Sponsor: NCI, Other
Protocol IDs: ANHL04B1, COG-ANHL04B1, NCI-2009-00406, NCT01000753
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: Under 31
Sponsor: NCI, Other
Protocol IDs: AALL05B1, COG-AALL05B1, CDR0000491159, NCT00897325
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: ALTE05N1, NCI-2009-00382, CDR0000590123, U10CA180886, U10CA098543, COG-ALTE05N1, NCT00736749
Start Over